世界のネブライザー市場2022-2030:種類別(ジェット式、メッシュ式、超音波式)、最終用途別(病院&クリニック、救急センター、在宅医療)

【英語タイトル】Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End Use (Hospitals & Clinics, Emergency Centers, Home Healthcare), And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GV22MY063)・商品コード:GV22MY063
・発行会社(調査会社):Grand View Research
・発行日:2022年4月22日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

グランドビューリサーチ社は、世界のネブライザー市場規模が2022年から2030年の間に年平均6.2%成長し、2030年までに17.7億ドルに達すると予測しています。本調査資料は、ネブライザーの世界市場について分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、種類別(ジェット式ネブライザー、メッシュ式ネブライザー、超音波式ネブライザー)分析、最終用途別(病院&クリニック、救急センター、在宅医療)分析、地域別分析、企業情報など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・世界のネブライザー市場規模:種類別(ジェット式ネブライザー、メッシュ式ネブライザー、超音波式ネブライザー)
・世界のネブライザー市場規模:最終用途別(病院&クリニック、救急センター、在宅医療)
・世界のネブライザー市場規模:地域別
・企業情報

Nebulizer Market Growth & Trends

The global nebulizer market size is expected to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2022 to 2030. The rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced a shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. This consequently promotes the demand for nebulizers. According to the Population Reference Bureau report, “Aging in the United States”, the geriatric population in the U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, the growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of the drug to the lung and lower residual volumes also aids in market growth. Furthermore, technological advancements such as drug-device combinations are further expected to create newer opportunities in the market. On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reducing drug loss.

Nebulizer Market Report Highlights

• The jet type segment held the largest revenue share of over 65.0% in 2021 owing to the greater penetration and low cost of the devices

• The mesh type segment is expected to register the fastest CAGR of 7.2% over the forecast period due to various benefits including portability, convenience, homecare application, and accurate dosage delivery

• The hospitals and clinics end-use dominated the market in 2021. Hospitals are an integral part of the healthcare industry and are the major revenue source for the entire industry

• The home healthcare end-use segment is expected to witness significant growth in the forecast period as home healthcare devices have been gaining popularity over the recent years

• North America dominated the market in 2021. This can be attributed to an increase in the incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and increased use of home care products

• Key players are also contributing to the market growth through partnerships, mergers and acquisitions, and the launch of new products. In March 2021, PARI Pharma GmbH revealed the LAMIRA Nebulizer System authorization for the delivery of Insmed’s drug product ARIKAYCE in Japan

❖ レポートの目次 ❖

Table of Content

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Type
1.1.2 End use
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3 Nebulizer Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Market influencer analysis
3.4 List of Key End Users
3.5 Regulatory Framework
3.5.1 Regulatory Landscape
3.6 Technology Overview
3.6.1 Nebulizer timeline analysis
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.2 Market restrain analysis
3.8 Nebulizer Analysis Tools: Porter’s
3.8.1 Supplier Power
3.8.2 Buyer Power
3.8.3 Threat of Substitutes
3.8.4 Threat of New Entrants
3.8.5 Competitive Rivalry
3.9 Nebulizer Market- SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.9.1 Political Landscape
3.9.2 Economic Landscape
3.9.3 Social Landscape
3.9.4 Technology Landscape
3.9.5 Legal Landscape
3.9.5 Respiratory Disease Prevalence
3.9.6 Major Deals and Strategic Alliances
Chapter 4 Nebulizer Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Competitive Analysis
4.2.1 Company market position analysis
4.2.2 Market leader
4.2.3 Innovators
4.2.4 Vendor Landscape
4.2.4.1 List of nebulizer service providers
Chapter 5 Nebulizer Market: Segment Analysis, By Type, 2017 – 2030 (USD Million)
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Nebulizer Market, by Type, 2017 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
5.5.1 Jet nebulizer
5.5.1.1 Jet nebulizer market, 2017 – 2030 (USD Million)
5.5.2 Mesh nebulizer
5.5.2.1 Mesh nebulizer market, 2017 – 2030 (USD Million)
5.5.2.2 Active
5.5.2.2.1 Active nebulizer market, 2017 – 2030 (USD Million)
5.5.2.3 Passive
5.5.2.2.1 Passive nebulizer market, 2017 – 2030 (USD Million)
5.5.3 Ultrasonic nebulizer
5.5.3.1 Ultrasonic nebulizer market, 2017 – 2030 (USD Million)
Chapter 6 Nebulizer Market: Segment Analysis, By End Use, 2017 – 2030 (USD Million)
6.1 Definition and Scope
6.2 End Use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Nebulizer Market, by End Use, 2017 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
6.5.1 Hospitals and Clinics
6.5.1.1 Hospitals and Clinics market, 2017 – 2030 (USD Million)
6.5.2 Emergency Centers
6.5.2.1 Emergency Centers market, 2017 – 2030 (USD Million)
6.5.3 Home Healthcare
6.5.3.1 Home Healthcare market, 2017 – 2030 (USD Million)
Chapter 7 Nebulizer Market: Regional Market Analysis, By Type and End Use, 2017 – 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Global Nebulizer Market, by Regions, 2017 to 2030
7.5 Regional Market Snapshot
7.6 Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030
7.7 North America
7.7.1 North America Market estimates and forecast, by country, 2017-2030 (USD Million)
7.7.2 North America Nebulizer market, by type, 2017 – 2030 (USD Million)
7.7.3 North America Nebulizer market, by end use, 2017 – 2030 (USD Million)
7.7.4 U.S.
7.7.4.1 U.S. Nebulizer market, 2017 – 2030 (USD Million)
7.7.5 Canada
7.7.5.1 Canada Nebulizer market, 2017 – 2030 (USD Million)
7.8 Europe
7.8.1 Europe Nebulizer market, by country, 2017 – 2030 (USD Million)
7.8.2 Europe Nebulizer market, by type, 2017 – 2030 (USD Million)
7.8.3 Europe Nebulizer market, by end use, 2017 – 2030 (USD Million)
7.8.4 U.K.
7.8.4.1 U.K. Nebulizer market, 2017 – 2030 (USD Million)
7.8.5 Germany
7.8.5.1 Germany Nebulizer market, 2017 – 2030 (USD Million)
7.8.6 France
7.8.6.1 France Nebulizer market, 2017 – 2030 (USD Million)
7.8.7 Italy
7.8.7.1 Italy Nebulizer market, 2017 – 2030 (USD Million)
7.8.8 Spain
7.8.8.1 Spain Nebulizer market, 2017 – 2030 (USD Million)
7.9 Asia Pacific
7.9.1 Asia Pacific Nebulizer market, by country, 2017 – 2030 (USD Million)
7.9.2 Asia Pacific Nebulizer market, by type, 2017 – 2030 (USD Million)
7.9.3 Asia Pacific Nebulizer market, by end use, 2017 – 2030 (USD Million)
7.9.4 Japan
7.9.4.1 Japan Nebulizer market, 2017 – 2030 (USD Million)
7.9.5 China
7.9.5.1 China Nebulizer market, 2017 – 2030 (USD Million)
7.9.6 India
7.9.6.1 India Nebulizer market, 2017 – 2030 (USD Million)
7.9.7 Malaysia
7.9.7.1 Malaysia Nebulizer market, 2017 – 2030 (USD Million)
7.9.8 Singapore
7.9.8.1 Singapore Nebulizer market, 2017 – 2030 (USD Million)
7.9.9 Philippines
7.9.9.1 Philippines Nebulizer market, 2017 – 2030 (USD Million)
7.9.10 Indonesia
7.9.10.1 Indonesia Nebulizer market, 2017 – 2030 (USD Million)
7.10 Latin America
7.10.1 Latin America Nebulizer market, by country, 2017 – 2030 (USD Million)
7.10.2 Latin America Nebulizer market, by type, 2017 – 2030 (USD Million)
7.10.3 Latin America Nebulizer market, by end use, 2017 – 2030 (USD Million)
7.10.4 Brazil
7.10.4.1 Brazil Nebulizer market, 2017 – 2030 (USD Million)
7.10.5 Mexico
7.10.5.1 Mexico Nebulizer market, 2017 – 2030 (USD Million)
7.11 MEA
7.11.1 MEA Nebulizer market, by country 2017 – 2030 (USD Million)
7.11.2 MEA Nebulizer market, by type, 2017 – 2030 (USD Million)
7.11.3 MEA Nebulizer market, by end use, 2017 – 2030 (USD Million)
7.11.4 South Africa
7.11.4.1 South Africa Nebulizer market, 2017 – 2030 (USD Million)
7.11.5 Saudi Arabia
7.11.4.1 Saudi Arabia Nebulizer market, 2017 – 2030 (USD Million)
Chapter 8 Nebulizer Market – Competitive Analysis
8.1 GE Healthcare
8.1.1 Company Overview
8.1.2 Product Benchmarking
8.1.3 Strategic Initiatives
8.2 OMRON Corporation
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.3 Koninklijke Philips N.V.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.4 PARI Pharma
8.6.1 Company overview
8.6.2 Product benchmarking
8.6.3 Strategic initiatives
8.5 Allied Healthcare
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.6 Aerogen
8.8.1 Company overview
8.8.2 Product benchmarking
8.8.3 Strategic initiatives
8.7 Briggs Healthcare
8.9.1 Company overview
8.9.2 Product benchmarking
8.9.3 Strategic initiatives
8.8 DeVilbiss Healthcare LLC
8.10.1 Company overview
8.10.2 Product benchmarking
8.10.3 Strategic initiatives
8.9 Vectura Group plc
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.10 Beurer GmBH
8.12.1 Company Overview
8.12.2 Product Benchmarking
8.12.3 Strategic Initiatives
8.12.4 KOL commentary

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 List of nebulizer service providers
Table 4 North America nebulizer market, by type, 2017 - 2030 (USD Million)
Table 5 North America mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 6 North America nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 7 U.S. nebulizer market, by type, 2017 - 2030 (USD Million)
Table 8 U.S. mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 9 U.S. nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 10 Canada nebulizer market, by type, 2017 - 2030 (USD Million)
Table 11 Canada mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 12 Canada nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 13 Europe nebulizer market, by type, 2017 - 2030 (USD Million)
Table 14 Europe mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 15 Europe nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 16 U.K. nebulizer market, by type, 2017 - 2030 (USD Million)
Table 17 U.K. mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 18 U.K. nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 19 Germany nebulizer market, by type, 2017 - 2030 (USD Million)
Table 20 Germany mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 21 Germany nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 22 France nebulizer market, by type, 2017 - 2030 (USD Million)
Table 23 France mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 24 France nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 25 Italy nebulizer market, by type, 2017 - 2030 (USD Million)
Table 26 Italy mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 27 Italy nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 28 Spain nebulizer market, by type, 2017 - 2030 (USD Million)
Table 29 Spain mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 30 Spain nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 31 Asia Pacific nebulizer market, by type, 2017 - 2030 (USD Million)
Table 32 Asia Pacific mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 33 Asia Pacific nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 34 Japan nebulizer market, by type, 2017 - 2030 (USD Million)
Table 35 Japan mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 36 Japan nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 37 China nebulizer market, by type, 2017 - 2030 (USD Million)
Table 38 China mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 39 China nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 40 India nebulizer market, by type, 2017 - 2030 (USD Million)
Table 41 India mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 42 India nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 43 Malaysia nebulizer market, by type, 2017 - 2030 (USD Million)
Table 44 Malaysia mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 45 Malaysia nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 46 Singapore nebulizer market, by type, 2017 - 2030 (USD Million)
Table 47 Singapore mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 48 Singapore nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 49 Philippines nebulizer market, by type, 2017 - 2030 (USD Million)
Table 50 Philippines mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 51 Philippines nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 52 Indonesia nebulizer market, by type, 2017 - 2030 (USD Million)
Table 53 Indonesia mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 54 Indonesia nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 55 Latin America nebulizer market, by type, 2017 - 2030 (USD Million)
Table 56 Latin America mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 57 Latin America nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 58 Brazil nebulizer market, by type, 2017 - 2030 (USD Million)
Table 62 Brazil mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 63 Brazil nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 64 Mexico nebulizer market, by type, 2017 - 2030 (USD Million)
Table 65 Mexico mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 66 Mexico nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 67 MEA nebulizer market, by type, 2017 - 2030 (USD Million)
Table 68 MEA mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 69 MEA nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 70 South Africa nebulizer market, by type, 2017 - 2030 (USD Million)
Table 71 South Africa mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 72 South Africa nebulizer market, by end use, 2017 - 2030 (USD Million)
Table 73 Saudi Arabia nebulizer market, by type, 2017 - 2030 (USD Million)
Table 74 Saudi Arabia mesh nebulizer market, by type, 2017 - 2030 (USD Million)
Table 75 Saudi Arabia nebulizer market, by end use, 2017 - 2030 (USD Million)

List of Figures

Fig. 1 Nebulizer market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Information procurement
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity Flow Analysis
Fig. 10 Nebulizer executive summary, 2021, (USD Millions)
Fig. 11 Nebulizer market revenues, 2021, (USD Millions)
Fig. 12 Segment outlook
Fig. 13 Strategy framework
Fig. 14 Parent market outlook
Fig. 15 Ancillary market outlook
Fig. 16 Market trends and outlook
Fig. 17 Penetration & growth prospect mapping
Fig. 18 Nebulizer market trend analysis
Fig. 19 Nebulizer market timeline analysis
Fig. 20 Market trends & outlook
Fig. 21 Market driver relevance analysis (Current & future impact)
Fig. 22 Treatment cost by healthcare setting (Average cost per day in USD)
Fig. 23 Global geriatric population, 2012 – 2020 (Million)
Fig. 24 Market restraint relevance analysis (Current & future impact)
Fig. 25 Porter’s five forces analysis
Fig. 26 PESTLE analysis
Fig. 27 Market participant categorization
Fig. 28 Nebulizer company market position analysis
Fig. 29 Respiratory diseases prevalence
Fig. 30 Type of nebulizers in respiratory diseases clinical trials
Fig. 31 Clinical trials by products
Fig. 32 Clinical trials by companies
Fig. 33 Nebulizer market type outlook: Key takeaways
Fig. 34 Nebulizer market: type movement analysis
Fig. 35 Jet nebulizer market, 2017 - 2030 (USD Million)
Fig. 36 Mesh nebulizer market, 2017 - 2030 (USD Million)
Fig. 37 Ultrasonic nebulizer market, 2017 - 2030 (USD Million)
Fig. 38 Nebulizer market end-use outlook: Key takeaways
Fig. 39 Nebulizer market: end-use movement analysis
Fig. 40 Hospitals and clinics market, 2017 - 2030 (USD Million)
Fig. 41 Emergency Centers market, 2017 - 2030 (USD Million)
Fig. 42 Home healthcare market, 2017 - 2030 (USD Million)
Fig. 43 Nebulizer market: regional movement analysis
Fig. 44 Regional market dashboard
Fig. 45 Nebulizer market regional outlook: Key takeaways
Fig. 46 Regional market place: Key takeaways
Fig. 47 North America nebulizer market, by country, 2017 - 2030 (USD Million)
Fig. 48 North America nebulizer market, by type, 2017 - 2030 (USD Million)
Fig. 49 North America nebulizer market, by end use, 2017 - 2030 (USD Million)
Fig. 50 U.S. nebulizer market, 2017 - 2030 (USD Million)
Fig. 51 Canada nebulizer market, 2017 - 2030 (USD Million)
Fig. 52 Europe nebulizer market, by country, 2017 - 2030 (USD Million)
Fig. 53 Europe nebulizer market, by type, 2017 - 2030 (USD Million)
Fig. 54 Europe nebulizer market, by end use, 2017 - 2030 (USD Million)
Fig. 55 U.K. nebulizer market, 2017 - 2030 (USD Million)
Fig. 56 Germany nebulizer market, 2017 - 2030 (USD Million)
Fig. 57 France nebulizer market, 2017 - 2030 (USD Million)
Fig. 58 Italy nebulizer market, 2017 - 2030 (USD Million)
Fig. 59 Spain nebulizer market, 2017 - 2030 (USD Million)
Fig. 60 Asia Pacific nebulizer market, by country, 2017 - 2030 (USD Million)
Fig. 61 Asia Pacific nebulizer market, by type, 2017 - 2030 (USD Million)
Fig. 62 Asia Pacific nebulizer market, by end use, 2017 - 2030 (USD Million)
Fig. 63 Japan nebulizer market, 2017 - 2030 (USD Million)
Fig. 64 China nebulizer market, 2017 - 2030 (USD Million)
Fig. 65 India nebulizer market, 2017 - 2030 (USD Million)
Fig. 66 Malaysia nebulizer market, 2017 - 2030 (USD Million)
Fig. 67 Singapore nebulizer market, 2017 - 2030 (USD Million)
Fig. 68 Philippines nebulizer market, 2017 - 2030 (USD Million)
Fig. 69 Indonesia nebulizer market, 2017 - 2030 (USD Million)
Fig. 70 Latin America nebulizer market, by country, 2017 - 2030 (USD Million)
Fig. 71 Latin America nebulizer market, by type, 2017 - 2030 (USD Million)
Fig. 72 Latin America nebulizer market, by end use, 2017 - 2030 (USD Million)
Fig. 73 Brazil nebulizer market, 2017 - 2030 (USD Million)
Fig. 74 Mexico nebulizer market, 2017 - 2030 (USD Million)
Fig. 74 MEA Nebulizer market, by country, 2017 - 2030 (USD Million)
Fig. 75 MEA Nebulizer market, by type, 2017 - 2030 (USD Million)
Fig. 76 MEA Nebulizer market, by end use, 2017 - 2030 (USD Million)
Fig. 77 South Africa Nebulizer market, 2017 - 2030 (USD Million)
Fig. 78 Saudi Arabia Nebulizer market, 2017 - 2030 (USD Million)

★調査レポート[世界のネブライザー市場2022-2030:種類別(ジェット式、メッシュ式、超音波式)、最終用途別(病院&クリニック、救急センター、在宅医療)] (コード:GV22MY063)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のネブライザー市場2022-2030:種類別(ジェット式、メッシュ式、超音波式)、最終用途別(病院&クリニック、救急センター、在宅医療)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆